Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29154228 | 0.77 | — | — | |
| SCHEMBL31739507 | 0.73 | HCAR2 (0.33) | HCAR2 | |
| SCHEMBL9052051 | 0.73 | — | — | |
| SCHEMBL5860682 | 0.71 | CD274 (0.33) | HCAR2 | |
| SCHEMBL2821686 | 0.71 | — | — | |
| SCHEMBL13326794 | 0.69 | HCAR2 (0.36) | HCAR2 | |
| SCHEMBL4500031 | 0.69 | HCAR2 (0.36) | HCAR2 | |
| SCHEMBL9551484 | 0.69 | HCAR2 (0.36) | HCAR2 | |
| SCHEMBL28193456 | 0.68 | SLC6A2 (0.35) | — | |
| Hydrochloric Acid SCHEMBL8131080 | 0.68 | HCAR2 (0.35) | HCAR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118119631-A | Programmable selective acylation of polyols | 南洋理工大学 | 2024-05-31 | — | — | CN | claimed |
| EP-3331886-A1 | DOPAMINE D3 RECEPTOR ANTAGONISTS HAVING A BICYCLO MOIETY | Indivior UK Limited (GB) | 2018-06-13 | — | — | EP | disclosed |
| WO-2017021920-A1 | DOPAMINE D3 RECEPTOR ANTAGONISTS HAVING A BICYCLO MOIETY | INDIVIOR UK LIMITED (GB) | 2017-02-09 | — | — | WO | disclosed |
| EP-1716143-A1 | POLYHETEROCYCLIC COMPOUNDS AND THEIR USE AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS | AstraZeneca AB (SE) | 2006-11-02 | — | — | EP | disclosed |
| WO-2005080386-A1 | POLYHETEROCYCLIC COMPOUNDS AND THEIR USE AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS | ASTRAZENECA AB (US) | 2005-09-01 | — | — | WO | disclosed |